Table 3.

Results of univariate and multivariate linear regression analyses based on the outcome of TMDP.

	Univariate			Multivariate
	P-value	Unstandardized Coefficients	95% C.I.	P-value	Unstandardized Coefficients	95% C.I.
Sex (male: 0, female: 1)	0.002	2.33	0.88 to 3.77	<0.001	2.48	1.12 to 3.85
Age: category	0.126	0.42	−0.12 to 0.95
Type of facility (Hospital: 0, Clinic: 1)	0.252	1.40	−1.01 to 3.82
Endemic area	0.279	−0.89	−2.51 to 0.73
At least one risk factor in the participant	0.670	0.29	−1.07 to 1.65
At least one risk factor in the cohabitant	0.108	1.10	−0.25 to 2.45
Living apart due to the pandemic	0.088	3.86	−0.59 to 8.31	0.041	4.28	0.18 to 8.34
COVID-19 infectious	0.979	0.10	−7.63 to 7.83
Vaccine
(None: 0, At least 1st dose: 1)	0.792	0.22	−1.45 to 1.89
Duration per test (min)	0.688	−0.001	−0.01 to 0.01
Test frequency (/2 weeks)	0.192	−0.01	−0.04 to 0.01
Unexpected test	0.703	0.28	−1.18 to 1.74
EEG with hyperventilation	0.646	0.33	−1.08 to 1.74
EEG monitoring	0.276	−0.75	−2.11 to 0.61
Test for outpatients	0.577	0.69	−1.74 to 3.11
Examination for patients (suspected) with COVID-19	0.359	−1.08	−3.41 to 1.24
Protocol or screening	0.977	0.04	−2.95 to 3.04
Counseling/Consultation office	0.114	−1.18	−2.64 to 0.29
Availability of N95 mask	0.177	−1.04	−2.56 to 0.48
Change in salary or bonus during the COVID-19 pandemic (Down: 0, No change: 1, Up: 2)	< 0.001	−1.77	−2.70 to −0.84	<0.001	−1.69	−2.58 to −0.80

C.I.: confidence interval; EEG: electroencephalography.

P < 0.10 in Univariate analysis and P < 0.05 in multivariate analysis indicated significance (in bold).